APA (7th ed.) Citation

JG, R., KPC, K., & FX, V. (2026). Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: Implications for therapeutic use. Molecular psychiatry, 31(8), 4799. https://doi.org/10.1038/s41380-026-03602-7

Chicago Style (17th ed.) Citation

JG, Ramaekers, Kuypers KPC, and Vollenweider FX. "Subjective and Neurocognitive Profiling of Clinical Doses of 3,4-methylenedioxymethamphetamine (MDMA) in Healthy Volunteers: Implications for Therapeutic Use." Molecular Psychiatry 31, no. 8 (2026): 4799. https://doi.org/10.1038/s41380-026-03602-7.

MLA (9th ed.) Citation

JG, Ramaekers, et al. "Subjective and Neurocognitive Profiling of Clinical Doses of 3,4-methylenedioxymethamphetamine (MDMA) in Healthy Volunteers: Implications for Therapeutic Use." Molecular Psychiatry, vol. 31, no. 8, 2026, p. 4799, https://doi.org/10.1038/s41380-026-03602-7.